FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1997517963> ?p ?o ?g. }

• W1997517963 endingPage "369" @default.
• W1997517963 startingPage "361" @default.
• W1997517963 abstract "Seeds and aerial parts of Peganum harmala L. are widely used in Algeria as anti-inflammatory remedies. Evaluation of Peganum harmala total alkaloids extracts and pure β-carboline compounds as an anti-inflammatory treatment by the inhibition of an enzyme key of inflammatory, myeloperoxidase (MPO) and HPLC quantification of the alkaloids from the different parts of plant. MPO inhibition was tested using taurine chloramine test. The inhibition of LDL oxidation induced by MPO was carried out. The molecular docking analysis of Peganum harmala alkaloids on MPO was performed using the Glide XP docking protocol and scoring function and the redox potential of alkaloids was determined using an Epsilon potentiostat. The concentration of harmala alkaloids was determined using HPLC analysis. The HPLC profiling of the active total alkaloids indicates that β-carboline e.g. harmine, harmaline, harmane, harmol and harmalol are major components. As β-carbolines resemble tryptamine, of which derivatives are efficient inhibitors of MPO, the harmala alkaloids were tested for their activity on this enzyme. Total alkaloids of the seeds and of the aerial parts strongly inhibited MPO at 20 µg/mL (97±5% and 43±4%, respectively) whereas, at the same concentration, those of the roots showed very low inhibition (15±6%). Harmine, harmaline and harmane demonstrated a significant inhibition of MPO at IC50 of 0.26, 0.08 and 0.72 µM respectively. These alkaloids exerted a similar inhibition effects on MPO-induced LDL oxidation. Molecular docking analysis of Peganum harmala alkaloids on MPO showed that all active Peganum harmala alkaloids have a high affinity on the active site of MPO (predicted free energies of binding up to −3.1 kcal/mol). Measurement of redox potentials versus the normal hydrogen electrode clearly differentiated (i) the high MPO inhibitory activity of harmine, harmaline and harmane (+1014, 1014 and 1003 mV, respectively); and (ii) the low activity of harmalol and harmol (+629/778 and 532/644 mV, respectively). A reverse phase HPLC method has been developed to determine simultaneously five alkaloids of Peganum harmala. Seeds contained all five β-carboline derivatives with the main active alkaloids, harmaline and harmine, being up to 3.8% and 2.9%, respectively. Up to 3.2% of harmine was determined in the roots. The four β-carboline derivatives, harmine, harmaline, harmane and harmalol were identified in the aerial parts. The highest inhibitory effect observed in seeds and the moderate effect of aerial parts could be explained by their harmine and harmaline content. In contrast, the very weak inhibition of the root extract, despite the presence of harmine, may tentatively be explained by the high concentration of harmol which can reduce Compound II of MPO to the native form. The inhibition of MPO by Peganum harmala β-carboline alkaloids, herein reported for the first time, may explain the anti-inflammatory effect traditionally attributed to its herbal medicine." @default.
• W1997517963 created "2016-06-24" @default.
• W1997517963 creator A5005772803 @default.
• W1997517963 creator A5010694491 @default.
• W1997517963 creator A5013914446 @default.
• W1997517963 creator A5035600406 @default.
• W1997517963 creator A5040095990 @default.
• W1997517963 creator A5040162102 @default.
• W1997517963 creator A5043717063 @default.
• W1997517963 creator A5048483620 @default.
• W1997517963 creator A5049191673 @default.
• W1997517963 creator A5058507929 @default.
• W1997517963 creator A5062778443 @default.
• W1997517963 creator A5072089774 @default.
• W1997517963 creator A5076114075 @default.
• W1997517963 creator A5076582688 @default.
• W1997517963 creator A5078913665 @default.
• W1997517963 creator A5082932007 @default.
• W1997517963 creator A5087966652 @default.
• W1997517963 date "2014-06-01" @default.
• W1997517963 modified "2023-10-16" @default.
• W1997517963 title "Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae)" @default.
• W1997517963 cites W123696023 @default.
• W1997517963 cites W1941212068 @default.
• W1997517963 cites W1956489988 @default.
• W1997517963 cites W1965126772 @default.
• W1997517963 cites W1968030645 @default.
• W1997517963 cites W1969631801 @default.
• W1997517963 cites W1975320957 @default.
• W1997517963 cites W1978847420 @default.
• W1997517963 cites W1980405844 @default.
• W1997517963 cites W1981633985 @default.
• W1997517963 cites W1982658870 @default.
• W1997517963 cites W1984217145 @default.
• W1997517963 cites W1985588649 @default.
• W1997517963 cites W1986589111 @default.
• W1997517963 cites W1989883879 @default.
• W1997517963 cites W2005985941 @default.
• W1997517963 cites W2008540071 @default.
• W1997517963 cites W2013170399 @default.
• W1997517963 cites W2016180784 @default.
• W1997517963 cites W2017772358 @default.
• W1997517963 cites W2021769399 @default.
• W1997517963 cites W2022767586 @default.
• W1997517963 cites W2027423337 @default.
• W1997517963 cites W2031938268 @default.
• W1997517963 cites W2032952413 @default.
• W1997517963 cites W2033293438 @default.
• W1997517963 cites W2035299293 @default.
• W1997517963 cites W2035418343 @default.
• W1997517963 cites W2036071267 @default.
• W1997517963 cites W2039963030 @default.
• W1997517963 cites W2051237707 @default.
• W1997517963 cites W2053283111 @default.
• W1997517963 cites W2055443457 @default.
• W1997517963 cites W2059149560 @default.
• W1997517963 cites W2059606407 @default.
• W1997517963 cites W2061423144 @default.
• W1997517963 cites W2075847948 @default.
• W1997517963 cites W2091171646 @default.
• W1997517963 cites W2092120060 @default.
• W1997517963 cites W2094945416 @default.
• W1997517963 cites W2095049412 @default.
• W1997517963 cites W2109853771 @default.
• W1997517963 cites W2111464898 @default.
• W1997517963 cites W2112284458 @default.
• W1997517963 cites W2127879496 @default.
• W1997517963 cites W2135503869 @default.
• W1997517963 cites W2137623306 @default.
• W1997517963 cites W2142360514 @default.
• W1997517963 cites W2151748867 @default.
• W1997517963 cites W2157764402 @default.
• W1997517963 cites W2160748613 @default.
• W1997517963 cites W2166129369 @default.
• W1997517963 cites W2184740085 @default.
• W1997517963 cites W4230038264 @default.
• W1997517963 cites W4241339248 @default.
• W1997517963 doi "https://doi.org/10.1016/j.jep.2014.03.070" @default.
• W1997517963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24746482" @default.
• W1997517963 hasPublicationYear "2014" @default.
• W1997517963 type Work @default.
• W1997517963 sameAs 1997517963 @default.
• W1997517963 citedByCount "49" @default.
• W1997517963 countsByYear W19975179632014 @default.
• W1997517963 countsByYear W19975179632015 @default.
• W1997517963 countsByYear W19975179632016 @default.
• W1997517963 countsByYear W19975179632017 @default.
• W1997517963 countsByYear W19975179632018 @default.
• W1997517963 countsByYear W19975179632019 @default.
• W1997517963 countsByYear W19975179632020 @default.
• W1997517963 countsByYear W19975179632021 @default.
• W1997517963 countsByYear W19975179632022 @default.
• W1997517963 countsByYear W19975179632023 @default.
• W1997517963 crossrefType "journal-article" @default.
• W1997517963 hasAuthorship W1997517963A5005772803 @default.
• W1997517963 hasAuthorship W1997517963A5010694491 @default.
• W1997517963 hasAuthorship W1997517963A5013914446 @default.
• W1997517963 hasAuthorship W1997517963A5035600406 @default.

• next